CHECK IT OUT: In this exclusive interview, Mike Guerra Mike Guerra explores the new era of #lifesciences, how the sector is prioritizing #innovation and accelerating drug discovery. He shares major milestones, challenges, & goals for the next five years. 👀bit.ly/3UWK9Tf

We applaud Congress for passing the Cardiovascular Advances in Research and Opportunities Legacy (CAROL) Act, which will support research and awareness of valvular heart disease. ♥ LEARN MORE about the CAROL Act: bit.ly/3usoMxu #heartdisease #research #CAROLAct

📢 JUST LAUNCHED #2023HealthTrends: Personally, Purposely Building What's Next. Syneos Health releases 13th annual Trends detailing the technological evolution that will lead to profound changes in how organizations think about and learn from data. bit.ly/3P8dTdw

WATCH: A message from Marc Fields, CLS SVP of Racial & Social Equity and Culture. With your help this year, we’ve worked to create a more diverse and equitable #lifesciences industry. #WeCommitToChange 👀 LEARN MORE about our 2022 impact: bit.ly/3W0wcDY

👋 We're happy to welcome one of our newest members, Colliers! They're a real estate advisory group that represents & advises biotech users during the facility procurement process. Reach out for any requirements in the San Francisco Bay Area, San Diego, or Cambridge markets.

Are you a #lifesicences entrepreneur who's ready to build and hone your business model, product development plan, and commercialization strategy? We encourage you to apply for our advisory program, FAST California! Learn more and apply by January 5 👉bit.ly/3PAMvVV

Economic slowdown? Great time to invest? Explore investment considerations in the cell and gene therapy market from David Crean of Cardiff Advisory, page 7 of Life Sciences Insights: bit.ly/3HTEauA #cellandgenetherapy #investment #LifeSciencesInsights

Get expert support for your investigational new drug application (IND), new drug application (NDA) or biologics license application (BLA). Connect with Cardinal Health's experienced team who has supported 90+ INDs & 155+ NDAs/BLAs in the past 5 years. bit.ly/3PIy5mJ #ad

Cell and gene therapies present unique reimbursement challenges, particularly for payers like Medicare. On pg 17 of Life Sciences Insights, Arnold & Porter shares why CGT companies should learn current payment systems. READ: bit.ly/3ZgQtYg #cellandgenetherapy

Early bird pricing for the #WorldAgriTech Innovation Summit ends this week! It's the annual meeting place for the AgTech ecosystem. Expect start-up discovery, partnerships & investment opportunities and C-Suite networking. Use code CALIFRIEND to save: bit.ly/3ZRMO3k

👏 Huge congratulations to Pantheon Award winner, RefleXion Medical, for receiving FDA clearance for SCINTIX therapy! Check it out: bit.ly/40qYQRr

NEWS ALERT 👀 CLS is spotlighted in the latest @Axios story, "Silicon Valley's biotech sector is still going strong," with insights from our own Brent Fisk and data from our 2023 Sector Report! Read how the #lifesciences sector anchors the local economy: bit.ly/3rU5jHQ

We recently brought together #lifesciences executives in the San Diego region to meet with legislators and have conversations about our sector in California. We toured Bristol Myers Squibb and Illumina, and we were delighted to have Senator Toni Atkins & Assemblymember Stephanie Nguyen cohost dinner.

🌟 Save the date for our inaugural Inclusive Leadership Symposium! Join #lifesciences leaders in San Francisco for a day of learning, reflection, and actionable change to embrace inclusion and equity. Register now: bit.ly/3umxSPr #HealthEquity #DEI #WeCommitToChange

FAST California has helped more than 119 #startups--like JAL Therapeutics--with their business models, product development plans, and commercialization strategies. 🚀 APPLY by Jan 6 for our 2024 spring cohort: bit.ly/3NQTv19 #FosteringInnovation

In partnership with JLABS, reps of NIA & NINDS will present an overview of the NIH SBIR program, NIA and NINDS funding opportunities, and special initiatives/resources for companies with innovative technologies. Apply by Jan 18 to meet one-on-one: bit.ly/3TTHZG7

We’re three weeks away from the Zoom course, From the Laboratory to Leadership 25th Anniversary Edition! This program addresses the unique challenges of the life sciences sector, providing a customized approach to meet your goals. Register: bit.ly/49N7DkP

A great conversation w/Dee Stahly (Dexcom), Jennifer Zims (CA Chronic Care Coalition) & Estela Mata (Looms4Lupus) with Assemblymember Mia Bonta discussing how #lifesciences innovation drives #patientacccess and #healthequity. This year's #LifeSciencesAcademy is off to an exciting start! 🌠

California Life Sciences (CLS) toured the Interdisciplinary Science Building San José State University. The 164k SF facility is a state-of-the-art teaching & research space for molecular-microbiology-chemistry & applied data sciences. SJSU houses the largest clinical lab scientist program in CA. Great work SJSU!

For our final speaker of the day, Stacie Calad-Thomson of NVIDIA is sharing her perspective on the future of life sciences with GenAI.